ArticleJournal of orthopaedic case reports2026
A Rare Presentation of Mandibular Bone Metastasis from Primarily Diagnosed Hepatocellular Carcinoma: A Case Report.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hepatocellular carcinoma (HCC), the sixth most frequently diagnosed malignancy, typically metastasizes to the lungs (55%), abdominal lymph nodes (41%), long bones (28%), and brain. Metastasis to the oral cavity, particularly the mandible, is an exceptionally rare phenomenon occurring in <1% of cases. In this case, the patient was presented as metastatic jaw malignancy without preceding any clinical symptoms or diagnosis of the primary intrahepatic tumor. Because these metastatic neoplasms lack pathognomonic clinical or radiological distinctions, they are frequently misdiagnosed as benign dental or maxillofacial conditions, such as periodontal disease or post-extraction complications. Accurate diagnosis is confirmed through histopathological studies identifying clusters of hepatocytes with sinusoid-like blood vessels, alongside immunohistochemistry demonstrating positive staining for human hepatocyte paraffin (Hepar 1) antibody. This report details the clinical course and complex palliative management of a patient whose occult Hepatitis C virus (HCV)-driven HCC first manifested as an aggressive mandibular mass. Case Report: A 62-year-old female presented with progressive right-sided mandibular swelling following a routine tooth extraction. A deep tissue jaw biopsy and immunohistochemical profiling confirmed metastatic HCC, Grade 2 (positive for Hepar-1 and Glypican 3). Staging investigations revealed a primary multi-lobar intrahepatic tumor, advanced liver cirrhosis, and portal hypertension secondary to a chronic, previously undiagnosed HCV infection linked to a 1987 blood transfusion. The patient received systemic Lenvatinib and palliative hypofractionated radiotherapy (3600 cGy in 12 fractions) to the mandible. Over 9 months, the disease rapidly progressed, culminating in an emergency admission with a bleeding, exophytic fungating mandibular mass, multi-lobar hepatic progression, left portal vein tumor thrombosis, and a new L3 spinal metastasis. Conclusion: This case highlights the diagnostic challenge of extrahepatic HCC masquerading as dental pathology and emphasizes the critical role of multidisciplinary palliative care in managing complex end-stage oncological complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.